Latest Insider Transactions at Quinstreet, Inc (QNST)
This section provides a real-time view of insider transactions for Quinstreet, Inc (QNST). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of QUINSTREET, INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of QUINSTREET, INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2024
|
Andrew T Sheehan Director |
SELL
Open market or private sale
|
Direct |
10,000
-15.38%
|
$210,000
$21.5 P/Share
|
|
Nov 19
2024
|
Gregory Wong CFO |
SELL
Open market or private sale
|
Direct |
22,896
-6.11%
|
$457,920
$20.91 P/Share
|
|
Nov 13
2024
|
Andrew T Sheehan Director |
SELL
Bona fide gift
|
Direct |
6,734
-9.39%
|
-
|
|
Nov 12
2024
|
Matthew Glickman Director |
SELL
Open market or private sale
|
Direct |
30,000
-10.85%
|
$660,000
$22.78 P/Share
|
|
Nov 11
2024
|
Stuart Huizinga Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
28,700
-13.63%
|
$660,100
$23.16 P/Share
|
|
Nov 10
2024
|
Douglas Valenti Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
26,537
+1.42%
|
-
|
|
Nov 10
2024
|
Douglas Valenti Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
26,537
-3.74%
|
-
|
|
Nov 10
2024
|
Douglas Valenti Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
27,275
-0.75%
|
$600,050
$22.5 P/Share
|
|
Nov 10
2024
|
Gregory Wong CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,555
-0.45%
|
$188,210
$22.5 P/Share
|
|
Nov 08
2024
|
Stuart Huizinga Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,300
-0.61%
|
$29,900
$23.01 P/Share
|
|
Oct 31
2024
|
Asmau Ahmed Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,904
+11.15%
|
-
|
|
Oct 31
2024
|
Matthew Glickman Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,904
+4.6%
|
-
|
|
Oct 31
2024
|
Stuart Huizinga Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,904
+3.16%
|
-
|
|
Oct 31
2024
|
David J Pauldine Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,904
+50.0%
|
-
|
|
Oct 31
2024
|
Andrew T Sheehan Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,904
+8.78%
|
-
|
|
Oct 31
2024
|
James R. Simons Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,904
+9.5%
|
-
|
|
Oct 31
2024
|
Hillary B Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,904
+11.33%
|
-
|
|
Oct 28
2024
|
David J Pauldine Director |
BUY
Bona fide gift
|
Indirect |
14,471
+7.85%
|
-
|
|
Oct 28
2024
|
David J Pauldine Director |
SELL
Bona fide gift
|
Direct |
14,471
-100.0%
|
-
|
|
Sep 12
2024
|
Gregory Wong CFO |
SELL
Open market or private sale
|
Direct |
41,855
-4.94%
|
$753,390
$18.61 P/Share
|
|
Aug 23
2024
|
David J Pauldine Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
10,099
-6.1%
|
$171,683
$17.59 P/Share
|
|
Aug 21
2024
|
David J Pauldine Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
901
-0.27%
|
$15,317
$17.55 P/Share
|
|
Aug 10
2024
|
Douglas Valenti Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
85,411
+4.48%
|
-
|
|
Aug 10
2024
|
Douglas Valenti Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
85,411
-10.38%
|
-
|
|
Aug 10
2024
|
Douglas Valenti Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
87,776
-1.42%
|
$1,492,192
$17.07 P/Share
|
|
Aug 10
2024
|
Gregory Wong CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,032
-0.75%
|
$391,544
$17.07 P/Share
|
|
Jul 31
2024
|
Douglas Valenti Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
214,540
-5.91%
|
-
|
|
Jul 30
2024
|
Douglas Valenti Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
570,000
+25.42%
|
-
|
|
Jul 30
2024
|
Gregory Wong CFO |
BUY
Grant, award, or other acquisition
|
Direct |
118,100
+12.32%
|
-
|
|
Jul 17
2024
|
Gregory Wong CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+10.81%
|
$160,000
$4.01 P/Share
|
|
May 10
2024
|
Douglas Valenti Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,783
-0.58%
|
$230,094
$18.47 P/Share
|
|
May 10
2024
|
Gregory Wong CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,065
-0.35%
|
$91,170
$18.47 P/Share
|
|
Feb 20
2024
|
Gregory Wong CFO |
SELL
Open market or private sale
|
Direct |
8,407
-2.77%
|
$126,105
$15.03 P/Share
|
|
Feb 10
2024
|
Gregory Wong CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,505
-0.36%
|
$82,575
$15.36 P/Share
|
|
Feb 10
2024
|
Douglas Valenti Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,352
-0.5%
|
$170,280
$15.36 P/Share
|
|
Dec 18
2023
|
Gregory Wong CFO |
SELL
Open market or private sale
|
Direct |
7,145
-2.26%
|
$85,740
$12.94 P/Share
|
|
Dec 15
2023
|
Gregory Wong CFO |
SELL
Open market or private sale
|
Direct |
25,865
-7.56%
|
$310,380
$12.85 P/Share
|
|
Nov 15
2023
|
Andrew T Sheehan Director |
SELL
Open market or private sale
|
Direct |
50,000
-43.54%
|
$550,000
$11.44 P/Share
|
|
Nov 15
2023
|
Andrew T Sheehan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+30.33%
|
$150,000
$3.4 P/Share
|
|
Nov 10
2023
|
Gregory Wong CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,036
-0.41%
|
$77,396
$11.09 P/Share
|
|
Nov 10
2023
|
Douglas Valenti Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,216
-0.65%
|
$167,376
$11.09 P/Share
|
|
Oct 27
2023
|
Stuart Huizinga Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,471
+6.59%
|
-
|
|
Oct 27
2023
|
Asmau Ahmed Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,471
+23.11%
|
-
|
|
Oct 27
2023
|
Anna Liao Fieler Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,471
+19.96%
|
-
|
|
Oct 27
2023
|
Matthew Glickman Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,471
+9.6%
|
-
|
|
Oct 27
2023
|
David J Pauldine Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,471
+34.74%
|
-
|
|
Oct 27
2023
|
James R. Simons Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,471
+19.73%
|
-
|
|
Oct 27
2023
|
Hillary B Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,471
+23.5%
|
-
|
|
Oct 27
2023
|
Andrew T Sheehan Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,471
+18.24%
|
-
|
|
Sep 18
2023
|
Douglas Valenti Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
2,500
+0.13%
|
$22,500
$9.0 P/Share
|